These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1989157)

  • 1. Prophylactic use of deoxyspergualin in living related renal transplantation.
    Okazaki H; Sato T; Jimbo M; Senga S; Amada N; Oguma S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1094-5. PubMed ID: 1989157
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic use of deoxyspergualin in a quadruple immunosuppressive protocol in renal transplantation.
    Koyama I; Amemiya H; Taguchi Y; Watanabe T; Nagashima N; Suzuki S; Omoto R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1096-8. PubMed ID: 1989158
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical application of 15-deoxyspergualin for treatment of acute graft rejection following renal transplantation.
    Suzuki S; Hayashi R; Kenmochi T; Shimatani K; Fukuoka T; Amemiya H
    Transplant Proc; 1990 Aug; 22(4):1615-7. PubMed ID: 2389422
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
    Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
    Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience gained from the administration of 15-deoxyspergualin for recurrent graft rejection in kidney transplant recipients.
    Takahara S; Jiang H; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1992 Aug; 24(4):1377-80. PubMed ID: 1496592
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic use of a new immunosuppressive agent, deoxyspergualin, in patients with kidney transplantation from ABO-incompatible or preformed antibody-positive donors.
    Takahashi K; Tanabe K; Ooba S; Yagisawa T; Nakazawa H; Teraoka S; Hayasaka Y; Kawaguchi H; Ito K; Toma H
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1078-82. PubMed ID: 1989153
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of 15-deoxyspergualin on experimental organ transplantation.
    Todo S; Murase N; Kahn D; Pan CE; Okuda K; Cemej S; Casavilla A; Mazzaferro V; Ghalab A; Rhoe BS
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):233-6. PubMed ID: 3279614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further study of deoxyspergualin prophylaxis in living related renal transplantation.
    Okazaki H; Sato T; Amada N
    Transplant Proc; 1993 Feb; 25(1 Pt 1):772-3. PubMed ID: 8438475
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of 15-deoxyspergualin on renal graft rejection.
    Kozaki K; Matsuno N; Sakurai E; Tamaki I; Furuhashi K; Saito A; Yoshida M; Miyamoto K; Kozaki M
    Transplant Proc; 1994 Aug; 26(4):1903-4. PubMed ID: 8066619
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the new immunosuppressive agent 15-deoxyspergualin and cyclosporine A after highly allogeneic pancreas transplantation.
    Schubert G; Stoffregen C; Timmermann W; Schang T; Thiede A
    Transplant Proc; 1987 Oct; 19(5):3978-9. PubMed ID: 3313974
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive effect of deoxyspergualin on acute renal allograft rejection in dogs.
    Fukao K; Otsuka M; Iwasaki H; Yuzawa K; Iwasaki Y
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1090-3. PubMed ID: 2650068
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of renal function in transplanted kidneys with a new immunosuppressive drug, 15-deoxyspergualin: treatment of chronic rejection.
    Iino Y; Ohzono E; Kawabe M; Matsunobu S; Takeuchi M; Hayama N; Hara K; Terashi A; Suzuki S; Amemiya H
    Transplant Proc; 1992 Aug; 24(4):1381-2. PubMed ID: 1496593
    [No Abstract]   [Full Text] [Related]  

  • 13. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates.
    Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B
    Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathological classification and clinical effects of kidney transplant rejection treated with 15-deoxyspergualin.
    Kyo M; Ichikawa Y; Fukunishi Y; Hanafusa T; Nagano S; Takahara S; Ishibashi M; Okuyama A; Ihara H; Fujimoto N
    Transplant Proc; 1995 Feb; 27(1):1012-3. PubMed ID: 7878780
    [No Abstract]   [Full Text] [Related]  

  • 15. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicentre clinical trial of antirejection pulse therapy with deoxyspergualin in kidney transplant patients.
    Amemiya H; Suzuki S; Ota K; Takahashi K; Sonoda T; Ishibashi M; Omoto R; Koyama F; Orita K; Takagi H
    Int J Clin Pharmacol Res; 1991; 11(4):175-82. PubMed ID: 1813436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective use of 15-deoxyspergualin in kidney transplantation.
    Koyama I; Kadokura M; Hoshino T; Omoto R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1088-9. PubMed ID: 2650067
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man.
    Ohlman S; Gannedahl G; Tydén G; Tufveson G; Groth CG
    Transplant Proc; 1992 Feb; 24(1):318-20. PubMed ID: 1539294
    [No Abstract]   [Full Text] [Related]  

  • 19. Establishment of rejection therapy with deoxyspergualin by multicentral controlled clinical studies in renal recipients.
    Amemiya H; Taguchi Y; Fukao K; Isono K; Omoto R; Ota K; Kosaki M; Takagi H; Oka T; Sonoda T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):730-3. PubMed ID: 8438462
    [No Abstract]   [Full Text] [Related]  

  • 20. Administration schedule of 15-deoxyspergualin and combination therapy with cyclosporin A in rat tail skin transplantation.
    Dickneite G; Schorlemmer HU; Racenberg J; Sedlacek HH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1097-8. PubMed ID: 2650069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.